Catalyst Wire Dossier Catalyst Wire Dossier

MEDI-546

· MedImmune LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MEDI-546, covering 2012-05-08 to 2019-07-31. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults [Phase 2]

See pricing